Magenta Therapeutics, Inc. Gains 51.66%

Fri, Feb 03, 2023 at 07:07 PM
Magenta Therapeutics, Inc. Gains 51.66%

Magenta Therapeutics, Inc. (MGTA:NASDAQ) shot up at $0.86, a gain of 51.7%. On Fri, Feb 03, 2023, MGTA:NASDAQ touched a New 2-Week High of $0.86. The stock appeared on our News Catalysts scanner on Wed, Jan 25, 2023 at 04:32 PM in the 'BIOTECH' category. From Fri, Jan 20, 2023, the stock recorded 60.00% Up Days and 63.64% Green Days

About Magenta Therapeutics, Inc. (MGTA:NASDAQ)

Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to bring the curative power of bone marrow transplant.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.